Enterprise Financial Services Corp (EFSC)’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-38
| Closed | -$13K | – | 491 |
|
|
2021
Q2 | $13K | Sell |
38
-251
| -87% | -$76K | ﹤0.01% | 673 |
|
|
2021
Q1 | $81K | Buy |
289
+35
| +14% | +$9.44K | 0.01% | 320 |
|
|
2020
Q4 | $62K | Sell |
254
-209
| -45% | -$53.9K | 0.01% | 341 |
|
|
2020
Q3 | $131K | Sell |
463
-8
| -2% | -$2.23K | 0.03% | 244 |
|
|
2020
Q2 | $126K | Hold |
471
| – | – | 0.03% | 248 |
|
|
2020
Q1 | $149K | Sell |
471
-4
| -0.8% | -$1.21K | 0.04% | 223 |
|
|
2019
Q4 | $141K | Buy |
475
+3
| +0.6% | +$832 | 0.03% | 250 |
|
|
2019
Q3 | $110K | Sell |
472
-24
| -5% | -$5.59K | 0.03% | 270 |
|
|
2019
Q2 | $116K | Sell |
496
-329
| -40% | -$76K | 0.03% | 279 |
|
|
2019
Q1 | $195K | Sell |
825
-55
| -6% | -$17.3K | 0.04% | 228 |
|
|
2018
Q4 | $265K | Buy |
880
+15
| +2% | +$4.79K | 0.17% | 107 |
|
|
2018
Q3 | $306K | Sell |
865
-60
| -6% | -$20.7K | 0.16% | 106 |
|
|
2018
Q2 | $268K | Sell |
925
-16
| -2% | -$4.5K | 0.14% | 121 |
|
|
2018
Q1 | $258K | Buy |
941
+25
| +3% | +$7.76K | 0.13% | 123 |
|
|
2017
Q4 | $292K | Sell |
916
-9
| -1% | -$2.89K | 0.14% | 120 |
|
|
2017
Q3 | $290K | Buy |
925
+889
| +2,469% | +$263K | 0.14% | 116 |
|
|
2017
Q2 | $10K | Sell |
36
-25
| -41% | -$6.61K | 0.01% | 575 |
|
|
2017
Q1 | $17K | Sell |
61
-99
| -62% | -$28K | 0.01% | 495 |
|
|
2016
Q4 | $45K | Buy |
160
+111
| +227% | +$32.9K | 0.02% | 287 |
|
|
2016
Q3 | $15K | Sell |
49
-19
| -28% | -$5.63K | 0.01% | 470 |
|
|
2016
Q2 | $16K | Sell |
68
-11
| -14% | -$2.9K | 0.01% | 442 |
|
|
2016
Q1 | $21K | Buy |
79
+27
| +52% | +$7.13K | 0.01% | 381 |
|
|
2015
Q4 | $16K | Sell |
52
-27
| -34% | -$7.76K | 0.01% | 441 |
|
|
2015
Q3 | $23K | Buy |
79
+32
| +68% | +$10.6K | 0.01% | 365 |
|
|
2015
Q2 | $19K | Sell |
47
-64
| -58% | -$25.7K | 0.01% | 417 |
|
|
2015
Q1 | $47K | Buy |
111
+8
| +8% | +$3.15K | 0.03% | 260 |
|
|
2014
Q4 | $35K | Buy |
103
+5
| +5% | +$1.62K | 0.02% | 310 |
|
|
2014
Q3 | $32K | Sell |
98
-23
| -19% | -$7.58K | 0.02% | 326 |
|
|
2014
Q2 | $38K | Sell |
121
-7
| -5% | -$2.11K | 0.02% | 314 |
|
|
2014
Q1 | $39K | Buy |
128
+7
| +6% | +$2.22K | 0.02% | 290 |
|
|
2013
Q4 | $34K | Hold |
121
| – | – | 0.02% | 307 |
|
|
2013
Q3 | $29K | Buy |
121
+10
| +9% | +$2.24K | 0.02% | 308 |
|
|
2013
Q2 | $24K | Buy |
+111
| New | +$23.7K | 0.02% | 300 |
|
Other funds holding BIIB
Enterprise Financial Services Corp (EFSC)'s BIIB Position: Q3 2021 in Review
Enterprise Financial Services Corp (EFSC) sold out of Biogen (BIIB) in Q3 2021, closing a stake of 38 shares — an estimated $13K sold.
Enterprise Financial Services Corp (EFSC) first reported a position in BIIB in Q2 2013 and held it in 33 quarters. The position peaked at $306K in Q3 2018. 1,040 funds tracked by Wall St. Rank hold BIIB as of Q3 2021.
- Enterprise Financial Services Corp (EFSC) reported no remaining Biogen position as of Q3 2021 after selling out during the quarter.
- Enterprise Financial Services Corp (EFSC) sold 38 Biogen shares in Q3 2021, an estimated $13K.
- Enterprise Financial Services Corp (EFSC) first reported a position in Biogen in Q2 2013 and held it in 33 quarters.
- Enterprise Financial Services Corp (EFSC)'s Biogen position peaked at $306K in Q3 2018.
- 1,040 funds tracked by Wall St. Rank held Biogen as of Q3 2021.
Based on Enterprise Financial Services Corp (EFSC)'s 13F filing for Q3 2021, filed 15 Nov 2021.